FDA Investigator Jeffrey M Watson

Jeffrey M Watson has conducted inspections on 135 sites in 1 countries as of 12 Apr 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
135
Last Inspection Date:
12 Apr 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jeffrey M Watson:
Abdur Razzaque, Alan L Truong, Alicia Gilbert, Alicia K Mckinsey, Alla Dubrovsky, Amir Alavi, Andrea A Branche, Andrea George, PhD, Andrew C Chang, Andrew Le, Andrew P Lin, Andrew W Harmon, Angel K Sandhu, Angela D Wise, Anh M Lac, Anita Narula, PhD, Ann Marie Montemurro, Ann Marie Schofield, Anney Lin, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Ashar P Parikh, Barbara J Wilcox, PhD, Bo Chi, PhD, Brentley S Collins, Bruce H Mccullough, Calvin B Koerner, Candace Y Gomez Broughton, Capri R Woolridge, Carl Lee, Carole L Jones, Carolyn A Renshaw, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Christian D Lynch (CDL), Christine M Parmentier, Christopher R Czajka, Claudia Mperez Kasmarski, Cynthia J Tsui, Cynthia Jim, CSO, Dandan Wang, PhD, Daniel C Geffin, Daniel J Roberts, Daniel Lagasse, Darlene B Almogela, David G Eng, Deborah Kleinfeld, Debra I Love, Diane Cvan Leeuwen, Diane L Raccasi, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Douglas A Campbell, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edward D Harris, Eileen A Liu, Elmina E Akwo, Emily Shacter, Emmanuel Adu Gyamfi, PhD, Ephrem Hunde, PhD, Eric L Dong, BS, Erica L Nicoll, Evelyn Wong, Francis J Eng, Gene D Arcy, Gerald Feldman, Gerald M Feldman, PhD, Gerald N Mcgirl, DDS, Gina M Hall, Gunneet Kaur, Gwyn G Dickinson, Helen B Ricalde, Henry K Lau, Hung H Do, MS, Ingrid A Zambrana, Italia Nappi, Jacqueline Mdiaz Albertini, James A Lane, James C Lee, PharmD, James R Evans, Jamie P Webb, Jannifer L Degroot, Jazmine M Welcher, Jeanne Fringer, PhD, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer Crumb, Jennifer L Degroot, Jennifer L Johnson, Joan T Briones, Joanne Hosting, Joey V Quitania, John A Gonzalez, Jolanna A Norton, Joseph George, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Joslyn K Brunelle, PhD, Juan A Morales, Julie D Bringger, Ka L Wong, Karen D Phung, Karen L Robles, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kenneth S Boehnen, Kevin P Foley, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Kula N Jha, Lakisha M Williams, Lakshmi Narasimhan, PhD, Lance Mde Souza, MBA, Laree A Tracy, Laura Fontan, MS, Laurie Graham, Laurie P Norwood, Laverne Puckett, Lawton W Lum, LCDR Jennifer H Rhyu, Lija V Fellows, Linan Ha, PhD, Linda S Shook, Linda Thai, Linh Tu, Lisa Shin, Lorna F Jones, Lucila B Nwatu, Lydia S Chan, Lynda L Perry, PhD, Mabel M Lee, Maida Henesian (NMI), Marcus F Yambot, Maria Cruz Fisher, Maridali Deleon Torres, Marie K Kinkade, Mariza M Jafary, Mark E Chan, Marsha W Major, Marshalette O Edwards, Mary Ewilkerson Brinsko, Mathew T Thomas, MD, Matthew R Clabeaux, Mei Chiung Huang (Jo), Michael D Kawalek, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Milos Dokmanovic, PhD, Min Shanmabel Liu, Monica Commerford, PhD, Monique C Lo, Nancy E Kirschbaum, Nancy T Waites, Natalia Pripuzova, PhD, Navneet Kaur, Nayan J Patel, Nicholas L Hunt, Nicholas Obiri, PhD, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Paula A Trost, Peter E Baker, Peter Kessler, PhD, Prabhu P Raju, Qing Joanna Zhou, PhD, Quynh H Strandberg, Ralph A Erickson, Ravi S Harapanhalli, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Reyes Candau Chacon, PhD, Richard L Bartlett, Richard Ledwidge (nmi), PhD, Richard W Thornton, Riley C Myers, PhD, Robert D Tollefsen, Robert Jennings, Roger D Gawne, Roman T Drews, PhD, Rose Ashley, Rumany C Penn, PharmD, Ruth Moore, PhD, Samina S Khan, Sandra S Saniga, Sangeeta M Khurana, PhD, Sara H Gabel, Scott N Lim, Seema S Singh, Serge L Beaucage, Sergio Chavez (NMI), Seyyida Saterfield, Sharon K Thoma, PharmD, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Simone E Pitts, Stephanie A Slater, MS, Stephen D Brown, Steven R Gillenwater, Stuart W Russell, Susan M Jackson, Tania Y Hall, Terrence Gee, Terry A Hook, DPh, Thea C Grome, Thomas J Arista, Thomas R Withers, Thomas W Gordon, Thuy T Nguyen, LCDR, Timothy C Grome, Todd M Bozicevich, Tracy Denison, PhD, Truong Xuan Nguyen (Andy), Uduak M Inokon, Uttaniti Limchumroon (Tom), Victoria L Morgan, Vijaya L Simhadri, Walden H Lee, Wayne L Jefferson, Willemsj, William J Foust, William V Millar, Yi Wang, PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Zuben E Sauna, PhD

Jeffrey M Watson's Documents

Publish Date Document Type Title
December, 2006 EIR Mylan Specialty, L.P. - EIR, 2006-12-04
April, 2007 FDA 483 Genentech, Inc. - Form 483, 2007-04-27
December, 2000 EIR Bayer HealthCare LLC - EIR, 2000-12-07
May, 2003 EIR Genentech, Inc. - EIR, 2003-05-07
August, 2005 EIR Alza Corporation - EIR, 2005-08-11
July, 2007 EIR Stiefel Laboratories Inc - EIR, 2007-07-25
June, 2004 FDA 483 ALZA Corporation - Form 483, 2004-05-14
September, 2005 EIR Alza Corp - EIR, 2005-09-08
July, 2000 EIR Oread Pharmaceutical Manufacturing Inc - EIR, 2000-07-07
July, 2010 FDA 483 Grifols Diagnostic Solutions Inc. - Form 483, 2010-07-15
February, 2009 FDA 483 Novartis Pharmaceuticals Corporation - Form 483, 2009-02-05
September, 2003 EIR Questcor Pharmaceuticals Inc. (Subsidiary of Mallinckrodt) - EIR, 2003-09-30
August, 2003 FDA 483 Penta Biotech Inc - Form 483, 2003-08-11
December, 2003 EIR Bausch Health Americas, Inc. - EIR, 2003-12-19
April, 2001 EIR Impax Laboratories, Inc. - EIR, 2001-04-20
December, 2009 EIR Bausch Health Americas, Inc. - EIR, 2009-12-10
April, 2012 FDA 483 ALZA Corporation - Form 483, 2012-04-20
November, 2011 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2011-11-03
August, 2009 EIR Genentech, Inc. - EIR, 2009-08-21
August, 2003 EIR Penta Biotech Inc - EIR, 2003-08-11
March, 2011 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2011-03-03
March, 2002 FDA 483 Bayer HealthCare LLC - Form 483, 2002-03-15
June, 2010 EIR Genentech, Inc. - EIR, 2010-06-23
February, 2001 EIR Allergan Sales, LLC - EIR, 2001-02-15
January, 2003 EIR Alza Corporation - EIR, 2003-01-06
June, 2004 FDA 483 ALZA Corporation - Form 483, 2004-06-16
April, 2007 EIR Genentech, Inc. - EIR, 2007-04-27
January, 2000 FDA 483 ASEGUA THERAPEUTICS LLC - Form 483, 2000-01-05
March, 2002 EIR Bayer HealthCare LLC - EIR, 2002-03-15
February, 2009 FDA 483 Bayer Healthcare Pharmaceuticals, Inc - Form 483, 2009-02-05
May, 2004 EIR Alza Corporation - EIR, 2004-07-12
June, 2004 EIR ALZA Corporation - EIR, 2004-07-12
May, 2000 EIR BPR Health International - EIR, 2000-05-15
October, 2004 EIR Alza Corporation - EIR, 2004-10-27
May, 2011 FDA 483 NuSil Technology LLC - Form 483, 2011-05-04
February, 2009 EIR Bayer Healthcare Pharmaceuticals, Inc - EIR, 2009-02-05
June, 2004 EIR ALZA Corporation - EIR, 2004-06-16
February, 2008 EIR Grifols Diagnostic Solutions Inc. - EIR, 2008-02-01
May, 2003 EIR Alza Corporation - EIR, 2003-05-14
December, 2000 FDA 483 Bayer HealthCare LLC - Form 483, 2000-12-07
October, 2002 EIR Impax Laboratories, Inc. - EIR, 2002-10-31
August, 2003 EIR AMPAC Fine Chemicals LLC - EIR, 2003-08-21
September, 2011 FDA 483 Genentech, Inc. - Form 483, 2011-09-27
February, 2001 FDA 483 Allergan Sales, LLC - Form 483, 2001-02-15
August, 2004 EIR Alza Corp - EIR, 2004-08-26
April, 2005 EIR ALZA Corporation - EIR, 2005-04-29
February, 2009 FDA 483 Response Bayer Healthcare Pharmaceuticals, Inc - Form 483R, 2009-02-27

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more